Citigroup
WINT

Citigroup’s Windtree Therapeutics Inc WINT Stock Holding History

Citigroup’s Portfolio WINT Stock Details WINT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-192
Closed – – 7736
2016
Q1 		$0 Sell
192
-16
-8% -$34 ﹤0.01% 8035
2015
Q4 		$1K Buy
208
+15
+8% +$62 ﹤0.01% 7475
2015
Q3 		$1K Sell
193
-62
-24% -$410 ﹤0.01% 7297
2015
Q2 		$2K Sell
255
-19
-7% -$267 ﹤0.01% 7210
2015
Q1 		$5K Sell
274
-205
-43% -$4.04K ﹤0.01% 6740
2014
Q4 		$8K Buy
479
+114
+31% +$2.51K ﹤0.01% 6564
2014
Q3 		$10K Sell
365
-11
-3% -$266 ﹤0.01% 6294
2014
Q2 		$9K Sell
376
-125
-25% -$3.19K ﹤0.01% 6237
2014
Q1 		$15K Sell
501
-34
-6% -$1.14K ﹤0.01% 6187
2013
Q4 		$17K Buy
535
+159
+42% +$4.97K ﹤0.01% 6235
2013
Q3 		$10K Hold
376
– – ﹤0.01% 6223
2013
Q2 		$8K Buy
+376
New +$9.26K ﹤0.01% 6212

Other funds holding WINT

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citigroup's WINT Position: Q2 2016 in Review

Citigroup sold out of Windtree Therapeutics Inc (WINT) in Q2 2016, closing a stake of 192 shares.

Citigroup first reported a position in WINT in Q2 2013 and held it in 12 quarters. The position peaked at $17K in Q4 2013. 33 funds tracked by Wall St. Rank hold WINT as of Q2 2016.

  • Citigroup reported no remaining Windtree Therapeutics Inc position as of Q2 2016 after selling out during the quarter.
  • Citigroup sold 192 Windtree Therapeutics Inc shares in Q2 2016.
  • Citigroup first reported a position in Windtree Therapeutics Inc in Q2 2013 and held it in 12 quarters.
  • Citigroup's Windtree Therapeutics Inc position peaked at $17K in Q4 2013.
  • 33 funds tracked by Wall St. Rank held Windtree Therapeutics Inc as of Q2 2016.

Based on Citigroup's 13F filing for Q2 2016, filed 12 Aug 2016.